CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN CTO Registry Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial Cardiopulmonary Exercise Testing: What Is its Value? 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study) A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice : An NCDR Registry to Practice Project Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain Hemodynamic Response to Nitroprusside in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies
|<<... 5 6 7 8 9 10 11 ...>>|

Consensus2019 Dec 27[Online ahead of print]

JOURNAL：Catheter Cardiovasc Interv. Article Link

SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography and Intervention

AR Shroff, Rajiv Gulati, DE Drachman et al. Keywords: transradial angiography; ultrasound; ulnar artery access; non-invasive testing of collateral flow; radial artery occlusion prevention

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top